Posts Tagged ‘GSK’

Sabine Vollmer

RTP Wrapup 8/28

Thursday, August 27, 2009, 6:27 pm By No Comments | Post a Comment

Duke University Health System announced plans for a $700 million cancer center, GlaxoSmithKline’s diet pill Alli is being investigated for possibly causing serious liver damage and Wall Street observers project a flurry of companies may try to go public after Labor Day.

Read more…